|
|||||
|
|
Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing |
|
| Authors: | Shelagh M Szabo Morten Hedegaard Keith Chan Kristian Thorlund Robin Christensen Henrik Vorum |
| Institution: | 1. Redwood Outcomes, Vancouver, Canada;2. Novartis Healthcare, Copenhagen, Denmark;3. The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Copenhagen, Denmark;4. Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark |
| Abstract: | |
| Keywords: | Age-related macular degeneration Network meta-analysis Systematic review Vascular endothelial growth factor inhibitors |